Pharma Investing Less in Canadian Research
The Patented Medicine Prices Review Board (PMPRB) published their 2017 report on August 22, noting $16.8 billion in patented medicines sold in Canada in 2017.
Read More
Category: Stories
Stories
Health Canada Defines a Rare Disease – Sort Of
This week, Health Canada updated their website to include information about the approval process for orphan drugs to treat rare diseases.
Read More
An ‘Ableist’ Bureaucracy Tried (and Failed) to Control an Artist with Down’s Syndrome
In Vancouver this evening, 49-year-old Teresa Pocock, local artist, poet, and ‘self-advocate’ with Down’s syndrome, will be hosting a book launch and art show.
Read More
Canada’s Gaucher Drug Bidding War
The standard of care for Canadians with Gaucher disease just changed. The drug costs per patient per year will be reduced by about $100,000 and it is all due to the pan-Canadian Pharmaceutical Agency (pCPA).
Read More
Health Canada Approves Gazyva to Treat Follicular Lymphoma
Health Canada has approved Gazyva (obinutuzumab) to treat patients with follicular lymphoma, a slow growing form of non-Hodgkin’s lymphoma (NHL).
Read More
Health Canada Approves New Prostate Cancer Drug
Health Canada has approved Erleada (apalutamide tablets) to treat patients with non-metastatic castration-resistant prostate cancer.
Read More
Health Canada Approves a Third Cystic Fibrosis Drug
Health Canada has approved a third drug by Vertex Pharmaceuticals, Symdeko (tezacaftor/ivacaftor and ivacaftor), to treat a subpopulation of people with cystic fibrosis (CF).
Read More
Biotech CEO Wants to Fix Canada’s Clinical Trial Problem
Boris Weiss, CEO of Medicare Pharmaceuticals, provides a brief overview of the difficulties to start clinical trials in Canada and his proposed pilot program to alleviate some of those difficulties.
Read More
